Selected Publications

08/24/10: Health Benefits from Tea: Perception vs. Reality

WellGen’s own Dr. Shiming Li presented research about the analytical method for measuring polyphenols and the polyphenol content in ready-to-drink tea beverages at the American Chemical Society (ACS) meeting that began August 22 [...]

Continue Reading...

Research

Nutrigenomics and natural products chemistry are integral parts of the WellGen research process in studying how natural products can provide solutions for diseases related to inflammation.

Clinical support for WellGen® theaflavin- rich black tea concentrate:

Human Clinical Study 1:

Systemic Inflammation Study LPS (lipopolysaccharide)- mediated challenge exposes the inflammation cascade and is a fundamental pharmaceutical inflammation probe.

Key findings

  • Reduces expression of pro-inflammatory mRNA and cytokines/chemokines proteins
  • Inflammatory biomarker levels ranging between two-to-four fold less than the placebo group
  • Elevation of immuno-modulatory cytokine IL-10

Human Clinical Study 2:

Exercise-induced Inflammation - Test the effects in high-intensity anaerobic exercise on:

  • Delayed onset muscle soreness (DOMS)
  • Oxidative stress
  • Cortisol response
  • Inflammatory biomarkers

Key findings

  • Reduces damage and inflammation due to exercise related stress
  • Promotes rapid post-exercise recovery
  • Improves capacity to exercise
  • Reduces oxidative stress markers
  • Relieves delayed onset muscle soreness due

© 2012 WellGen Inc. | 330 Madison Avenue, 31st Floor | New York, New York 10017 | Phone: 212.210.6282
Home | About Us | Research | Business Development | Investors | Contact Us | Terms and Conditions